Who has invested in Vicore Pharma?

Nippon Shaku are named among the investors backing Vicore Pharma.

Vicore Pharma Funding: $120M Raised, Series C (2021)

Vicore Pharma funding overview

Vicore Pharma is based in Boston, MA. Vicore Pharma has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in November 2021. The round record for Vicore Pharma runs through 2021; nothing later has been disclosed. Investors on record include Nippon Shaku.

Vicore Pharma at a glance

Total raised: $120M
Latest round: Series C
Latest round date: November 2021
Headquarters: Boston, MA
Notable investors: Nippon Shaku

Frequently asked about Vicore Pharma funding

How much has Vicore Pharma raised?: Vicore Pharma has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Vicore Pharma?: Nippon Shaku are named among the investors backing Vicore Pharma.
What was the latest Vicore Pharma funding round?: The most recent disclosed round is a Series C, announced in November 2021.
Where is Vicore Pharma based?: Vicore Pharma is based in Boston, MA.
When did Vicore Pharma last raise?: The last disclosed Vicore Pharma round closed in November 2021 at Series C.

We update the Vicore Pharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.

Vicore Pharma Funding: $120M Raised, Series C (2021)

Vicore Pharma funding overview

Vicore Pharma at a glance

Frequently asked about Vicore Pharma funding

Companies related to Vicore Pharma (18)

Browse related funding lists (5)